The estimated Net Worth of James Corbett is at least $6.92 million dollars as of 10 September 2018. James Corbett owns over 4,175 units of Revvity stock worth over $5,440,996 and over the last 13 years James sold PKI stock worth over $1,479,423.
James has made over 6 trades of the Revvity stock since 2014, according to the Form 4 filled with the SEC. Most recently James exercised 4,175 units of PKI stock worth $109,176 on 10 September 2018.
The largest trade James's ever made was exercising 57,126 units of Revvity stock on 19 June 2014 worth over $1,188,221. On average, James trades about 3,884 units every 67 days since 2012. As of 10 September 2018 James still owns at least 47,194 units of Revvity stock.
You can see the complete history of James Corbett stock trades at the bottom of the page.
James's mailing address filed with the SEC is 940, Winter Street, Prospectville, Waltham, Middlesex County, Massachusetts, 02451, United States.
Over the last 26 years, insiders at Revvity have traded over $204,298,889 worth of Revvity stock and bought 55,200 units worth $1,110,570 . The most active insiders traders include Alexis P Michas, Gregory L Summe et Robert F Friel. On average, Revvity executives and independent directors trade stock every 25 days with the average trade being worth of $6,184,617. The most recent stock trade was executed by Andrew Okun on 13 April 2023, trading 2,435 units of PKI stock currently worth $332,402.
PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to serve the diagnostics, life sciences, food, and applied markets. IT strategically partners with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Its dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index.
Revvity executives and other stock owners filed with the SEC include: